Research & Development in
Geneva

Fondation Sanfilippo Suisse

Since 2008 · 1–10 empl.

The core activity of the company is to promote and support research and help for people with Sanfilippo disease, a rare genetic disorder. The company, Fondation Sanfilippo Suisse, is involved in organizing fundraising campaigns, team-building events and other activities to collect money and attention for the disease. It also provides information about the disease and the research related to it, and enables companies and individuals to engage as partners or donors.

FONDATION AGALMA

Since 2010 · 21–50 empl.

The core activity of the Fondation Agalma consists of conducting interdisciplinary research and organizing seminars, conferences and workshops that focus on the interfaces between neuroscience, psychoanalysis and art. The foundation aims to develop new questions and ideas and to promote exchange between researchers from different disciplines.

Descartes Institute for the Future Sàrl

Since 2011 · 11–20 empl.

The company 'Descartes Institute for the Future' primarily focuses on researching and analyzing future topics, particularly in the areas of innovation, technology, and urban development. The core activity of the company is to provide research and consulting services to private and public organizations to support them in shaping their future viability. The company also creates various rankings and indices, such as the 'Smart City Index', which measures the future viability of cities. Furthermore, the company publishes books, articles, and presentations on topics such as innovation, urban development, and sustainability. Overall, the core activity of the company can be described as 'research and consulting in the field of future development and innovation'.

eKlore Sàrl

Since 2011 · 11–20 empl.

The core activity of eKlore is applied research and development in the field of computer science.

Ali&Co Genève SA

Since 2011 · 1–10 empl.

Ali&Co Genève SA manufactures Swiss made wristwatches and markets them, including the Mysterali collection. The Mysterali models use a patented quartz "mysterious" movement and a transparent dial where the hands appear to move without a visible mechanism.

Neurix SA

Since 2011 · 11–20 empl.

The core activity of Neurix SA is the development and provision of human stem cell-based services for drug discovery and development, particularly in the field of neurology. This includes the creation of 3D neural tissue models, the development of in vitro models for neurodegenerative diseases, and the conduct of high-throughput screenings for the evaluation of drug candidates.

scMetrology SARL

Since 2013 · 1–10 empl.

The core activity of scMetrology SARL is the characterization of superconductors, particularly in the measurement of their electromechanical properties. The company offers services such as measuring critical current as a function of magnetic fields, temperatures, and mechanical stresses. It works closely with the University of Geneva and other laboratories to perform these measurements. Another focus of the company is the development of TMC conductors, which are considered the next generation of high-field superconductors.

Global Action For Fungal Infections (GAFFI)

Since 2013 · 21–50 empl.

Global Action For Fungal Infections (GAFFI) is a foundation focused on reducing death and suffering from fungal infections. GAFFI promotes timely diagnosis and access to antifungal treatment in low- and middle-income countries, supports regional hubs and networks, and maintains resources connecting clinicians, researchers, diagnostics providers and policy stakeholders.

Fondation Campus Biotech Geneva

Since 2013 · 21–50 empl.

Fondation Campus Biotech Geneva operates Campus Biotech as a life-sciences hub focused on neuroscience, neurotechnology and digital health. The foundation provides research space, scientific platforms and services such as meeting rooms, event organization, catering and prototyping workshops.

Wyss Center for Bio and Neuro Engineering

Since 2014 · 101–500 empl.

The core activity of the Wyss Center is the development and implementation of innovative technologies and therapies in the field of neurology and neuroscience, particularly for the treatment of neurological and psychiatric disorders. This includes research and development of new technologies, support for start-ups, and collaboration with industry partners to bring these innovations into clinical practice. The Wyss Center combines experts from various disciplines such as neuroscience, engineering, software development, and data analysis to develop transformative solutions.

DONA Foundation

Since 2014 · 21–50 empl.

The core activity of DONA Foundation is the development, standardization and management of Digital Object Architecture (DOA) and Handle System, a system for identifying and managing digital objects. The company promotes the use of DOA and Handle System in various industries and supports the development of applications and tools based on this technology.

Eoswiss-Engineering SARL

Since 2014 · 1–10 empl.

The core activity of Eoswiss is the provision of services and development of products for the pharmaceutical and biotechnology industries, particularly in the areas of: * Technology transfer and production transfer * Process development and scale-up * Supply chain management and efficiency enhancement * Quality management and GMP (Good Manufacturing Practice) * Project management The company also offers specific products and services such as: * Intelligent scale-up process development and digitalization * Process optimization * Precise freeze-drying * Polarized light - optical inspection * Process analytical technology (PAT) and AI (Artificial Intelligence) * Virtual factory simulation The company positions itself as an expert in interdisciplinary projects in the pharmaceutical and biotechnology industries.

SPACECODE Diamonds SA

Since 2014 · 21–50 empl.

The core activity of Spacecode is the development and provision of intelligent inventory management solutions for the high-end industries of diamonds, jewelry and healthcare. This includes the combination of RFID-controlled hardware, unique LED tags and customized software to provide advanced solutions for inventory management, diamond identification and process automation.

CELL RECEPTOR SA

Since 2015 · 1–10 empl.

CELL RECEPTOR SA develops a novel cell-biology-based therapy for cancer and autoimmune diseases. It researches an extracellular signalling mechanism and develops compounds that block interactions between tumour cells and platelets to reduce tumour growth, metastasis and chemoresistance.

La Fondation Apprendre Genève

Since 2016 · 11–20 empl.

The core activity of The Geneva Learning Foundation is to conduct research, development and scaling of new learning and leadership approaches to address critical threats to society. The company focuses on creating collective capacity for transformation and supporting organizations in addressing challenges through innovative learning and leadership approaches.

iOnctura SA

Since 2017 · 21–50 empl.

The core activity of iOnctura is the development of cancer drugs, particularly in oncology immunotherapy, with a focus on solid tumors, uveal melanoma and other types of cancer.

HORIZON Group sàrl

Since 2018 · 11–20 empl.

The core activity of Horizon Group is to conduct research and analysis as well as develop solutions in the fields of economy, sustainability, and social innovation. Specifically, this includes: Developing indices and benchmarks, Conducting research projects and analyses, Creating reports and studies on topics such as competitiveness, risks, and sustainable growth, Developing strategies and partnerships for companies and organizations, Supporting companies and governments in improving their competitiveness and sustainability. The company positions itself as an expert in research and analysis and offers its customers solutions based on comprehensive data analysis and expert knowledge.

Association pour le soutien de l'Institut International de l'Europe du Sud-est pour les Technologies Durables (SEEIIST)

Since 2019 · 21–50 empl.

The core activity of the company SEEIIST (South East European International Institute for Sustainable Technologies) is the development and implementation of hadron beam therapy and biomedical research with protons and heavy ions, particularly in South-Eastern Europe. The company aims to create a platform for education and training for young scientists, researchers, technicians, medical doctors and biomedical engineers to drive technological and medical development in the region.

All Here SA

Since 2020 · 11–20 empl.

All Here SA is a meditation‑centric organisation that integrates practice, scientific research and technology. It develops the Silent Mind program, the Quantified Meditation System™ for EEG‑guided assessment and Quantified Meditation Reports, an XR/VR training platform and the Silent Mind mobile app, and runs research initiatives including the Bio‑Intelligence Initiative and meditation labs.

Owkin (Switzerland) Sàrl

Since 2020 · 11–20 empl.

The company is primarily active in the development of artificial intelligence (AI) and machine learning for the healthcare and pharmaceutical industries. The core activities include the development of AI platforms for drug discovery, development and diagnostics, as well as providing solutions for clinical research and development. The company also offers services to the pharmaceutical industry, such as developing strategic partnerships and providing data analysis and management solutions.

Bedoukian Research Switzerland Sàrl

Since 2021 · 11–20 empl.

Bedoukian Research Switzerland Sàrl develops and supplies flavor and fragrance ingredients and specialty chemicals for food and beverage, personal care, home care, and fine fragrance applications. The company also provides custom manufacturing and toll processing services.

Davos Alzheimer's Collaborative (Genève)

Since 2021 · 21–50 empl.

The core activity of Davos Alzheimer's Collaborative (DAC) is to mobilize a global partnership to combat Alzheimer's disease. This includes, in particular: Improving the early detection and diagnosis of Alzheimer's disease through innovative technologies and research; Preparing health systems worldwide for the introduction of new therapies and treatment methods; Conducting clinical trials and research programs; Collaborating with organizations, governments, and NGOs to promote Alzheimer's research and combat. DAC focuses specifically on developing programs and initiatives that improve the early detection and diagnosis of Alzheimer's disease, such as the Accurate Diagnosis Program and the Early Detection Program.

Re-State Foundation

Since 2022 · 11–20 empl.

The core activity of reState Foundation is the establishment and development of the world's first MetaUniversity, with the organization focusing on four pillars: research, technology, awareness raising and financing.

HealthAI

Since 2022 · 21–50 empl.

The company I-DAIR is engaged in the development and implementation of artificial intelligence (AI) and machine learning in various industries such as healthcare, education and finance. The core activity of the company lies in the research, development and implementation of intelligent systems and products based on AI and machine learning.

53 East Holding SA

Since 2022 · 1–10 empl.

The core activity of Dr. Scent is the development, manufacture and marketing of fragrance solutions for private and commercial applications, including room fragrance devices, fragrance oils, scented candles, room fragrance sticks and textile fresheners.

Release Therapeutics SA

Since 2005 · 1–10 empl.

The core activity of Relief Therapeutics is the development and marketing of new, patented therapeutics for rare and ultra-rare diseases, particularly for patients with severe illnesses for which there are currently no or only limited treatment options. The company focuses on developing medications for specific diseases such as Epidermolysis Bullosa, Phenylketonuria and other rare conditions.

Geneva Biotech Center (GBC) SA

Since 2013 · 11–20 empl.

The core activity of Atopia Tx is the development of innovative therapies for asthma and allergic diseases, in particular the development of a first disease-modifying therapeutic for asthma and allergies based on a molecule from Helicobacter pylori.

Biostime Institute for Nutrition and Care

Since 2017 · 1–10 empl.

The company's core activity is the promotion of research and development in the field of health and nutrition, particularly in the areas of maternal and child health, microbiome health, immune system and allergies, as well as brain development. The company supports scientific research through the awarding of grants, the organization of conferences and symposia, and collaboration with leading universities, hospitals and academic institutions.

Fondation CanSearCH

Since 2011 · 21–50 empl.·5.0(2)

The core activity of CANSEARCH is the promotion and conduct of research in the field of pediatric oncology and hematology, particularly in the development of personalized treatment methods and the improvement of clinical care for children and adolescents with cancer.

AMAL THERAPEUTICS SA

Since 2012 · 21–50 empl.·5.0(2)

The core activity of AMAL Therapeutics is the development of therapeutic cancer vaccines, particularly using its proprietary KISIMA immunization technology, which aims to stimulate the patient's immune response against cancer cells.

United Health Futures SA

Since 2020 · 1–10 empl.

The company UHF (United for Health) is a think tank and consulting firm specializing in the development of sustainable solutions to global challenges in the areas of health, development, and social inequality. The company's core activities include: Strategic consulting and support for organizations in developing sustainable strategies and policies; Conducting research and analysis in the field of health and development; Developing innovative solutions and technologies for global challenges; Coordinating and networking with actors from science, politics, economy, and civil society; Implementing sustainable and evidence-based policies and programs. The company pursues an interdisciplinary approach, combining expertise from various fields to develop comprehensive solutions to complex problems.

Simon Institute for Longterm Governance

Since 2023 · 11–20 empl.

The company 'Simon Institute for Longterm Governance' primarily focuses on researching and designing strategies for long-term and sustainable governance, particularly in light of the impact of technology and artificial intelligence on global society. The core activities include: Research and analysis on the impact of technology and artificial intelligence on global society and governance; Development of strategies and recommendations for long-term and sustainable governance; Organization of workshops and conferences with experts and decision-makers to coordinate multilateral actions; Creation of reports and publications on the results of research and the institute's work; Collaboration with international organizations, governments, and other stakeholders to implement the results of research and the institute's work. The company specifically concentrates on the topics of existential risks, artificial intelligence, global risks, and sustainable governance.

THE SMELL & TASTE LAB Sàrl

Since 2017 · 1–10 empl.

The core activity of "The Smell & Taste Lab" is to advise and support customers in the development of products and strategies in the field of olfactory and gustatory perception. This includes, among other things, the creation of product concepts, the conduct of research studies in the field of sensory neuroscience, the development of fragrances and multi-sensory signatures, as well as the creation of scientific evidence for ingredients, products, and brands. The company also offers educational and training programs, such as team workshops and olfactory reeducation, and has a network of industry experts, start-ups, institutions, and academic institutions. The core activities of the company can be summarized as follows: product development and strategy, research and development in the field of sensory neuroscience, fragrances and multi-sensory signatures, scientific consulting and evidence, education and training, and network building and maintenance.

Youth & Earth Sàrl

Since 2023 · 1–10 empl.

Youth & Earth Sàrl sells dietary supplements focused on longevity, cellular energy, and performance. Its range includes NMN capsules, resveratrol, creatine, and berberine products, as well as supplement bundles.

Social Complexity Lab Geneva Sàrl

Since 2018 · 1–10 empl.

Social Complexity Lab Geneva Sàrl provides decision-relevant analysis and tools to policy and business actors addressing complex social challenges. The Lab applies evidence-driven computational models and data-driven methods—including natural language processing, machine learning and geospatial analytics—to deliver analyses, software tools, training and embedded project support for designing and assessing interventions.

Ekynov Sàrl

Since 2021 · 11–20 empl.

The core activity of Ekynov Sarl is the development, manufacture and marketing of protective masks for horses, particularly for the prevention of equine rhinopneumonitis.

Scientis SA

Since 2016 · 21–50 empl.·5.0(2)

The core activity of Scientis SA is the development and manufacture of cosmetic products, particularly skin care products for the treatment of hyperpigmentation and melasma. The company focuses on research and development of products based on the use of cysteamine, an active ingredient used to correct pigment disorders. Scientis' products are intended to be applied to the human body to clean, beautify, promote attractiveness and alter appearance.

IRIM Fondation du Dr Béatrice Milbert

Since 2021 · 11–20 empl.

The core activity of the company is the promotion of research and development in the field of integrative medicine, particularly in the areas of Lyme disease, electrohypersensitivity and quantum medicine. The company, Irim Foundation, is led by Dr. Beatrice Milbert and aims to support and promote independent research and development in these areas.